Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pop on Friday great news. IMO something is brewing and it ain’t beer or coffee.
Looks solid into close. Covid is all the rage now and for the foreseeable future. Cases ramping up as winter and holidays approach. To fellow shareholders stay safe and your families. Leronlimab will be given EUA very soon in light of the substandard drugs that are being used now. The writing is on the wall. Whether in U.K. or the Philippines or in the U.S. or Canada something will give soon. Too much death around the corner as it lags infections. Don’t see any more Stephen Hahn attacks on twitter feed. All it takes is the right contact to open the door. Being in the right place at the right time is pertinent. I am expecting a big release by Friday. Something big could be right around the corner and I’m not blinking IMHO
The next week will be chaotic for the markets. Presidential elections, Covid ramping back up, social unrest and no stimulus will delay green shoots in the interim. Good news will not rocket the stock until we get definite answers and acceptances and dates. Patience will pay off. Tax loss sales are not a huge decision for many. Most who lost big on CYDY have sold already. So don’t let this scare tactic. The market is waiting on news of effective vaccines, results of elections and stimulus which will come sooner than later regardless of who gets electrd
Eli Lilly getting $375 million for their monoclonal antibody that trial was stopped for no efficacy, and pivoting to mild to moderate shich they feel will help patients. Something is seriously wrong here. One can only surmise that the cushy relationship that BP has with government and their lobbying really pays off. U.K. approvals will make a total mockery of the U.S. healthcare system and expose the massive pay to play culture.
No more pre-existing conditions. Leronlimab to the rescue. Diabetes = shot of Leronlimab =GONE
HEART DISEASE= shot of Leronlimab = GONE
CANCER ALZHEIMERS LUPUS GET A SHOT DONE
Higher lows will hold rest of week. New base is forming. This PR news was credible and timely. Mahoob will get the job done, present the data and complete file and review will happen quickly. Two weeks is a short time fram but all the data is in and mostly compiled. With a true CSO who knows how to get BLAs done, I am quite confident 3rd x will be a charm and MHRA will move forward on it rather quickly.
I backed up the truck today. Spent the inheritance. Thanks mom and dad. You always told me I was gonna be somebody and now I am. Helping solve the worlds diseases being invested in the next wonder drug. The next penicillin. RIP
Here is the huge unknown. Let’s say we get that one approval for BLA or Covid. Off label will be available and CYDY will ask for it’s use almost immediately. Will the big pharma be very interested in a full buyout knowing the pipeline that Leronlimab has going for it? NP can surely barter for the best offer as an approval opens the door to so many more options and opportunities.
Today’s PR has teeth to it. No longer is Leronlimab just a pipe dream. In two weeks time we will see if the hiring of MR Mahoob and this filing was a match made in heaven and a smart move. Looks like the GM has finally found a quarterback that compliments the team and pushes forward the vision as a whole. Priorities are now set. Get an approval ASAP and off label will follow. Smartest move was to go outside the US especially with all the turmoil around election and screw ups with the FDA and HHS and NIH. Fauci will be exposed very soon, as will the rest of them. Lining up all the ducks to form a perfect row is what is needed. Hiring Mahoob poured the foundation for the cement to be poured and a structure to be built. In due time more like a mansion with all the luxuries as each approval comes about. The share price will stay positive in the near term with a new base forming and a slow and steady rise from today. Looks like the Phoenix will rise from the ashes. GLTA
The biggest game changer that is not being talked about is vaccines. Warp speed and BO in bed and a race to get vaccines out and that will get all the headlines. Therapeutics will take a back seat to them. That is why the long haulers play such a big part of the equation. This trial will be done quickly and if protocols equal treatment it will be a lock to get approval. BLA looks like 4-6 months approval oversees. Let’s complete CD-12 trial rapidly and get results out ASAP. We know under NP timeline he said 2/4 weeks. I’m sure that means 3/6 weeks then 42 days from that. Then 2 weeks from that for results. Earliest timeline realistically will be end of January. That is 4 months compared to six for BLA best case scenario. Some dilution will occur maybe 25 million shares. But with strong catalysts in the pipeline it will not affect share price too much
Looks like we have a Green Day brewing tomorrow. Should be a shiny quarter. Then in two weeks a diver half dollar. Then in 4-6 weeks a Benjamin
I’m deciphering secret code now. Insider buying check. Eli Lilly trial stopped no efficacy check. Many others stopped ditto check. Meeting with MHRA check PR in the morning check. FDA granting EUA based on interim check. Stock at $5.00 by end of week ?
Uncle Jordan coming through with 200k. Maybe NEWS 2 is getting around. Leronlimab to the rescue. Feeling a big up day tomorrow. I’m backing up the truck early. That is the ice scream truck. I scream Leronlimab for the win. Go bears take LA to the cleaners +6.5
Since big Fox interview with Neil Cavuto which pushed stock up to $3.87, this stock had had minimal news that shareholders were hoping for. Knowing that interim was hyped at 195 and waiting for EUA which was a very slight possibility, was all near term to hope for. It was good news what DSMC said but not enough to push stock higher.
Misiu commend you for diligence and your contributions to Leronlimab. Same with Rockleo and others. The drug itself can’t do all the work while the management does none. The message is convoluted in how to properly assign in matter of importance that needs to be addressed. When NP spreads Leronlimab around like cream cheese on a bagel the message gets lost. All focus should be making sure the sites for S/C are firing on all cylinders. Getting patients enrolled asap is imperative. In my field you always take care of the crisis on hand to stop it. Once they played into Covid, that should have been their hand, but NP had to be told by FDA to stop using for EINDs and start trial. There is no proactivity in management only reactionary measures. We were told many months ago about U.K. trial sites and due to complications they may still not be up and running. BLA was not accepted. Why? Is or was that really the dirty work of the FDA delaying it asking for more data and suggesting that higher does would work better? Unknown at this time, but NP himself said we had results at 325 that is being discussed with MHRA today for two years sitting on the shelf. Garbled messages and lack of focus as to what should be priority is the reason this stock lingers. Of course you add misleading shareholders to vote for 100 million additional shares and then grant yourself and board 25% under the guise of talent pool and sell shares while pumping stock are bad indicators. Lead by example. Have some insider buying go on right now if you brag about stock being triple digit. Show it and produce results instead of being rewarded for delays and bs.
Ok four more days this week minus 2 more proactive videos and a fluff PR with a nothingburger, add a pickle and some ketchup a side of fries and you get .40c discount. So I’m a buyer at $1.88 going into this weekend. That’s about right where CYDY will be, especially when we get the good update that CD-12 trial enrollment is now 232
I heard the next revenue raise is gonna be a go fund me page attached to get out the vote campaign for Leronlimab pitchman Nader Pourhassan. Each dollar donated gets you one dream catcher.
PR today and we are not down 10% yet? Maybe things are starting to look up from her. But wait there are still 25 minutes to market close. Maybe I spoke too early.
What time should I get the popcorn ready for the PR for today’s meeting with U.K. ? Or should I wait til Wednesday?
My u derstanding is take everything NP puts out there with a grain of salt. The boy who cried wolf o e too many times. Regardless of what goes on, near term is what is on the table. What’s most likely is not much until S/C is fully enrolled and interim at 293. More Covid now than the first wave and expected to get worse. Politics is big at this time with election right around the corner. If Trump loses lame duck for next two months for transition and that if results are not contested and delayed through court challenges. Market down big today on fears of new lockdowns around the world and here in USA. Fear factor and fatigue of Covid are creeping back. Will FDA back Leronlimab ? Have they even taken a look at data 195
I think it’s safe to say that for those that have gotten in on ground floor and have been patient longs for many years, there is a lot more tolerance albeit waning in the poor management and their decisions. However, it is easier to tolerate when price bought into was under a buck. Although hurtful to see stock keep on tumbling, still not at a loss. There are many others that did not enjoy the pre $1 stock. That is why there are a lot of jumpers here creating pressure to the downside. Time is the enemy of many and reading through the tea leaves, the chart shows very little support above $2, unless some miracle shot makes it past the goalie. That is near term where many see delays, low cash and an unproven track record of this CEO to get things done. I understand impatience to some degree, but it is more of the unrealistic timelines and distorted PRs that make this stock vulnerable. Fortunately, there will be a need for more than vaccines and MABS and therapeutics will play a big part. The government is putting about 80-90% of their efforts into vaccines. This can further hurt share price especially next month when they will broadly announce approvals for a few of them. It may take 6-9 months before full rollout. CYDY needs to make their mark soonAs they will get pushed down farther to the bottom being a small company with low cash and limited exposure. It’s bottom of the eighth and the closer is warming up in the bullpen. We have 6 outs left.
So just read that the EU would approve a vaccine with less than 50% efficacy. The way COVID-19 has ramped up I guess they are grasping at anything. Meanwhile back at the ranch we wait for 63 more patients to fill 75%. Then wait another 42 days. I sure hope the FDA gets it right.
Biggest problem with CYDY is being the bug on the windshield. Small OTC company gains very little traction. Very small footprint that has been around for a long time advancing what should be a home run drug for HIV, booting the sure groundout making many errors. Then the fabrications by a CEO who refuses to acknowledge mistakes, live up to them and make necessary corrections. When one only hears themself speak and is not open to debate and discussions, this becomes a major downfall. I think NP has bipolar disorder. Depending on which way the wind is blowing, that is the direction he goes. How many times on CCs has he told us that he was going to do and by the next CC he doesn’t mention it again, or says we are not gonna do that, next question. Transparency has to work both ways. Street fighter label may be good but as the expression goes Typical dego bringing a knife to a gunfight. This may be the Alamo for CYDY. Longs are trying to keep the faith based on the science and potential, but without a proper leader and strategy, the mistakes are alarmingly becoming the norm.
Good afternoon CYDY. What are the chances for anything coming out of Monday’s meeting with MHRA? Do we have a chance with pre BLA? Or is this just another swing and a miss with a lengthy PR touting huge optimism form NP? Just seems like anything we hear comes from him and not worded well with lots of we hope and pray ? Just need confirmation of real news? Timelines? Hoping not too much dilution which we all know will happen very soon. Warrants being excercised ! Maybe
Naders last job was at a gas station with all the pumping he does. Convoluted message on proactive. Monday morning will be bad. Always ten percent drop after he speaks, just wasn’t enough time at end of day for shorts to bury this stock. Really want to hear something substantial after meeting on Monday with MHRA. Also trying my Phillipines contact to see what could be done. He has the same conch shell phone as my man Snoop Dog. Hope he isn’t too busy
Oh boy if the stock wasn’t down enough we get a proactive pump 15 minutes before the closing bell. Why Lord on earth would he do that? To try and calm the shareholders nerves?
Ok time for me to go on Gilead ihub to talk short and what a bad drug with nasty side effects. Let’s see how that works. Go Leronlimab Go Cydy
Looks like selling picked up a bit today. Not sure how many longs will remain in this. Looks like many might have averaged up when all NP great news and pump PRs were flowing only to be dealt bad cards and info. Don’t blame many for not taking whatever little profit might be squeezed before this drifts lower. I feel the MHRA is just an informational exchange at best. Very much a long shot at this time. Question is how big NP pumps it out as to what really was discussed. Mahoob may be on board but with only a week to review all the info it is doubtful much will occur. As far as Covid, Leronlimab will be effective and most likely approved but not before 293 interim and DSMC recommendations at that time. For S/H sake and cydy existence moving forward on Covid, results need. To be excellent.
I go by my chart, astrological anddwhat side of bed I wake up on and if it’s cloudy or sunny. Hasn’t been many up days in the past few months, so it would appear that as far as this stock goes, it’s been cloudy and rainy. Sure can use some good news need sunshine and vitaminD. I hold a very large position and not happy with the crap NP has dealt us for 60-90 days, with no change in sight. He reeks of desperation. Moves are always made in hindsight. There is always a bright PR put out there to attempt to keep stock from falling. I love especially when he gives airtime to shorts.
Bloodbath today. Might hit that elusive $2 plenty of selling here. No news. No approvals. No funding. Grip and hopester have been spot on in their analysis.
See u on the other side of a nickel. Hopester s t/a is spot on. I will set my sight on $2 tomorrow and make big money. No chance anything is gonna happen. Company CEO is like the bad news bears. He has no clue what to do. The bright lights of running this company have blinded him and the massive dilution coming will blind all of you. Best case scenario is for a buyout and they won’t be getting much.
Something tells me Cydy is gonna rocket to $1.50.
The message seems clear. Need to unblind and go oversees to foreign lands. What a shame
Buyout coming I can just smell it. I’ll take $4 bucks a share. That’s about how much Leronlimab is worth right now
Next week this stock will move up on approval from MHRA for HIV BLA meeting with U.K. The product and results at 350 for combo are just too good while FDA continues to make a mockery of itself. What a shame that only chance to gain any approvals near term has to come from outside the good ole US of A. What has this country become? Time to flip the script on the government’s control of private industry. The BP and their lobbyists s bills control the outcomes of people’s lives based on their blood soaked cash bribe hands.
Can’t believe Remdesivir is the SOC in 50 countries and now with full approval to be used off label and being produced in over 40 locations with 2 million doses. But it takes 6 vials for 5 day treatment. So Leronlimab may still have a go at it
RemDeathIsNear full approval. Stake in the heart. Talk about deflating news. What a bad omen. Looking like BP wins again with direct access to Fauci and NIH. Cytodyn better stop with Covid and resume 100% with BLA and Mahoob getting it right this time. Couple latest news of full approval and slow enrollment in trial for CD-12 it just appears that cydy is losing out
The only shot Leronlimab has is if they start long haulers trial asap. Then show quick enrollment and great efficacy. Then I will load up. Depending on of course the trial protocols set being realistic and achievable. This will be filled way quicker than S/C trial. Could have results by end of January. That’s a big if? FDA must approve trial end points. If all that happens, you have a winner take all as no one is even attempting to cure those long haulers.
I haven’t slept in weeks, months, just waiting to blink
Shorts are real fearful of news over the weekend. We better cover blah blah blah. U have been using that same language since the big fail June 30 th. Glad I didn’t pay attention woulda lost out on all the winnings and big moves to the upside. Keep deluding yourself that stock will be $4 then $5 then as NP says triple digits. The big .001